Clinical Trial Update: Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating duloxetine in patients with diabetic peripheral neuropathic pain with or without comorbid major depressive disorder has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Neuropathies, Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2011-10-31